en · de · es · fr · pt
semax-notes.peptides1126.com › Guide › Semax Background And Molecular Structure — Quick Reference

Semax Background And Molecular Structure — Quick Reference

By Editorial Desk · published 2025-11-21 · last reviewed 2025-12-26 · Guide

melanocortin signalling is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Updated 2025-12-26. Numbers and descriptions here follow the published literature rather than marketing material.

Semax Background and Molecular Structure

Reported pharmacological work centers on neurotrophic signaling, including changes in BDNF and NGF expression in hippocampal tissue in animal models. Human data come largely from studies conducted in Russia, and how well those results generalize to other populations remains an open question. Regulatory status differs sharply by jurisdiction: Semax is a registered prescription medicine in Russia, while it holds no approved marketing status in the United States or the European Union. Outside such jurisdictions it is generally handled as a research chemical, which affects both documentation and quality expectations.

Semax is a synthetic heptapeptide whose sequence is Met-Glu-His-Phe-Pro-Gly-Pro. It was developed as a fragment analog of adrenocorticotropic hormone, modeled specifically on the ACTH(4-10) region. The first four residues reproduce that fragment, while a Pro-Gly-Pro tripeptide is appended at the C-terminus. Work on the compound originated in Russia, where it entered clinical use as an intranasal preparation. Its sequence places it among short regulatory peptides studied for effects on the central nervous system rather than on the adrenal axis.

The C-terminal Pro-Gly-Pro extension is not incidental. Proline-rich tails are known to resist several common peptidases, and the published literature attributes the longer half-life of Semax, relative to unmodified ACTH fragments, to this feature. The modification also removes the melanocyte-stimulating and corticosteroidogenic activity that characterizes longer ACTH-derived sequences. Because the molecule is small and hydrophilic, it is typically formulated as an aqueous solution for intranasal or parenteral delivery. Acetylation or amidation at the termini appears in closely related research peptides and shifts the mass by a fixed increment.

Semax Peptide Structure and Origin

Terminology around the compound varies by source. It appears in catalogues and papers as Semax, as the heptapeptide ACTH(4-7)-Pro-Gly-Pro, and under various alphanumeric laboratory codes used by individual suppliers. These names refer to the same sequence but may imply different salt forms, purity grades, or counter-ions. Peptide databases usually list the free base mass, while product descriptions sometimes report acetate or trifluoroacetate salts with a different formula weight. Because naming conventions for research peptides are not standardised across vendors, checking the declared sequence and measured mass is more reliable than relying on a trade name alone.

Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. Its design combines the ACTH(4-7) core fragment with a C-terminal Pro-Gly-Pro extension, a modification intended to improve stability and prolong activity. The molecule is hydrophilic, carries no lipid chains or glycosylation, and has a theoretical mass just over 810 daltons in its free form. All seven residues are proteinogenic amino acids, so no non-natural building blocks appear in the backbone. A free N-terminal methionine and C-terminal proline define the unmodified parent peptide.

Semax at a glance

PropertyValueNotes
Molecular weight~813.9 Da (free heptapeptide)N-acetylated form is about 42 Da heavier
Residue count7 (heptapeptide)Four residues from ACTH(4-10), three added
AppearanceWhite to off-white powderUsually supplied lyophilized
Solubility classFreely soluble in waterAlso dissolves in DMSO and polar organic solvents
Related parent fragmentACTH(4-10)Parent motif is Met-Glu-His-Phe

Semax Origin and Molecular Structure

Semax is a synthetic heptapeptide with the sequence Met-Glu-His-Phe-Pro-Gly-Pro. It is described in the literature as an analogue of the ACTH(4–10) fragment, a short N-terminal portion of adrenocorticotropic hormone that retains some neurotropic activity without the full hormonal effects of the parent peptide. The molecule carries a methionine residue at the N-terminus and two proline residues near the C-terminus, features that shape both its interactions with receptor systems and its chemical stability. The free peptide corresponds to the formula C37H51N9O10S and a molecular mass near 813.9 Da.

The compound was developed in the 1980s at the Institute of Molecular Genetics in Moscow, where it emerged from research on short ACTH fragments and their effects on the central nervous system. Russian pharmaceutical listings describe it as a nootropic and neuroprotective agent, most often formulated as nasal drops. It is not a marketed medicine in the United States or the European Union, and no pharmacopoeial monograph covers it. Consequently, most published clinical experience with the substance originates from a small number of research centres, mainly in Russia and neighbouring countries.

Pharmacological accounts link semax to melanocortin signalling and to modulation of neurotrophic factor expression, particularly brain-derived neurotrophic factor and nerve growth factor. Much of this evidence comes from rodent studies using intranasal delivery, a route chosen because it allows peptides to reach the central nervous system with limited systemic exposure. Whether the same mechanisms operate in humans at comparable magnitude remains an open question. The precise receptor or receptors responsible for the reported behavioural and neuroprotective effects have not been conclusively identified.

Related pages on this site

Background and Development History

Regulatory status varies sharply by country. Semax is registered for medical use in Russia, where it appears in formularies as a nasal solution, and it also holds registration in a small number of neighbouring states. It has no approval from the United States Food and Drug Administration or the European Medicines Agency, and it is not a scheduled controlled substance in most jurisdictions. Elsewhere it circulates mainly as laboratory material, so purity documentation comes from suppliers rather than from a national pharmacopoeia.

Semax is a synthetic peptide created in the Soviet Union during the early 1980s by researchers working in Moscow. It was built from the short adrenocorticotropic hormone fragment known as ACTH(4-10), and the chain was then extended with three additional amino acids. The resulting molecule was named semax and entered clinical use in Russia in 1994. It is generally described as a nootropic and neuroprotective agent rather than as a hormone analogue.

Supporting material

In the United States, drug costs are partially unregulated, but instead are the result of negotiations between drug companies and insurance companies. High prices have been attributed to monopolies given to manufacturers by the government. New drug development costs continue to rise as well. Despite the enormous advances in science and technology, the number of new blockbuster drugs approved by the government per billion dollars spent has halved every 9 years since 1950.

=== Via biodegradation of trifluomethyl compounds === Trifluoroacetic acid is not produced biologically, but it is a breakdown product of various organofluorine compounds, e.g., the volatile anesthetic agent halothane. It also may be formed by hydroxyl radical-initiated atmospheric oxidation of the commonly used refrigerant 1,1,1,2-tetrafluoroethane (R-134a). Moreover, it is formed as an atmospheric degradation product of almost all fourth-generation synthetic refrigerants, also called hydrofluoroolefins (HFO), such as 2,3,3,3-tetrafluoropropene. Trifluoroacetic acid is also formed by the degradation of some pesticides that contain a trifluoromethyl group (-CF3), such as flufenacet. The German Environment Agency estimated that pesticide use releases approximately 500 metric tonnes of TFA annually in Germany alone, while refrigerants account for around 1170 metric tonnes per year.

When not flying, bats hang upside down from their feet, a posture known as roosting. Most megabats roost with the head tucked towards the belly, whereas most microbats roost with the neck curled towards the back. This difference is due to the structure of the cervical or neck vertebrae in the two groups, which are clearly distinct. Tendons allow bats to hang from a roost with no effort, which is needed to release. Bats are more awkward when crawling on the ground, though a few species, such as the New Zealand lesser short-tailed bat (Mystacina tuberculata) and the common vampire bat (Desmodus rotundus), are quite agile. These species move their limbs one after the other, but vampire bats accelerate by bounding, the folded-up wings being used to propel them forward. Vampire bats likely evolved these gaits to stalk their hosts, while short-tailed bats took to the ground due to a lack of competition from other mammals. Terrestrial locomotion does not appear to affect their ability to fly.

There is, however, little research on whether female condoms are as effective as male condoms at preventing STIs, and they are slightly less effective than male condoms at preventing pregnancy, which may be because the female condom fits less tightly than the male condom or because it can slip into the vagina and spill semen. The vaginal lymph nodes often trap cancerous cells that originate in the vagina. These nodes can be assessed for the presence of disease. Selective surgical removal (rather than total and more invasive removal) of vaginal lymph nodes reduces the risk of complications that can accompany more radical surgeries. These selective nodes act as sentinel lymph nodes. Instead of surgery, the lymph nodes of concern are sometimes treated with radiation therapy administered to the patient's pelvic, inguinal lymph nodes, or both. Vaginal cancer and vulvar cancer are very rare, and primarily affect older women. Cervical cancer (which is relatively common) increases the risk of vaginal cancer, which is why there is a significant chance for vaginal cancer to occur at the same time as, or after, cervical cancer. It may be that their causes are the same. Cervical cancer may be prevented by pap smear screening and HPV vaccines, but HPV vaccines only cover HPV types 16 and 18, the cause of 70% of cervical cancers. Some symptoms of cervical and vaginal cancer are dyspareunia, and abnormal vaginal bleeding or vaginal discharge, especially after sexual intercourse or menopause. However, most cervical cancers are asymptomatic (present no symptoms).

==== Absorption of HMB-Ca ==== After ingestion, HMB-Ca is converted to β-hydroxy β-methylbutyrate following dissociation in the gut. When the HMB-Ca dosage form is ingested, the magnitude and time at which the peak plasma concentration of HMB occurs depends on the dose and concurrent food intake. Higher HMB-Ca doses increase the rate of absorption, resulting in a peak plasma HMB level (Cmax) that is disproportionately greater than expected of a linear dose-response relationship and which occurs sooner relative to lower doses. Consumption of HMB-Ca with sugary substances slows the rate of HMB absorption, resulting in a lower peak plasma HMB level that occurs later.

Sources: en.wikipedia.org

Notes from published material

After passing the OBBBA, Congress needed to approve a new spending bill to fund the federal government beyond October 1, 2025, when the previous budget expired. The 53 Republican senators had to either eliminate the filibuster or convince at least seven Democrats to join them in order to reach the 60-vote supermajority required to advance their proposal. Most Democrats opposed the Republican plan and requested a compromise that would extend the healthcare subsidies cut by the OBBBA. The resulting stalemate triggered the 2025 United States federal government shutdown, which became the longest government shutdown in U.S. history.

In June 2023, lead investigator Claise recused himself after the lawyer of Tarabella, one of the accused, raised allegations of a conflict of interest, due to the fact that Claise's eldest son ran a company with the son of Arena, an associate of Panzeri. The prosecutor's office said that the action was taken due to "the substantial work he and his investigators have done in this case" and "the absence of any real evidence to cast doubt on the probity of any of the parties involved." Claise was replaced by Aurélie Dejaiffe. The Court of Appeal ruled, in February 2026, that there had been no conflict of interest, but Claise had in the meantime retired.

=== Securing air and sea visibility in the GIUK gap === Until 2007, the Faroe Islands were home to an air surveillance radar station, providing vital radar coverage during the Cold War. In light of broader geopolitical changes, such as the Russian invasion of Ukraine, c. 2022, the station was undergoing preparations to be reopened, closing an important surveillance gap in the GIUK gap. Maintaining thorough surveillance of the GIUK gap is crucial in order to ensure that sea lines of communication (SLOCs) and supply lines are uninterrupted between NATO's European members and the United States. Military bases, space bases, surveillance drones and radar installations in both Greenland and the Faroe Islands can help ensure proper visibility in the region, and assist in anti-submarine warfare (ASW) in case of actual conflict. In 2021, Denmark unveiled a $250 million investment in surveillance capabilities in Greenland and the Faroe Islands. Responding to requests from NATO for Denmark to play its part in securing Arctic waters, Denmark is taking further steps to equip its ASW-frigates with sonar equipment, making them better equipped to detect and track submarines in the Arctic Ocean, and particularly in the GIUK gap. In addition, the Danish government is equipping its Seahawk helicopters with sonar equipment and torpedoes. The upgrades have yet to be delivered, however, with delivery projections estimating 2024 at the earliest.

== Behavior == Nocturnal and arboreal, the Wagler's pit viper appears quite sluggish, as it remains motionless for long periods of time waiting for prey to pass by. When prey does pass by, or if disturbed, it can strike quickly.

Sources: en.wikipedia.org

Further detail

== Cast == Claes Bang as Johan Otto von Spreckelsen Sidse Babett Knudsen as von Spreckelsen's wife Liv Xavier Dolan as Jean-Louis Subileau Swann Arlaud as Paul Andreu Michel Fau as François Mitterrand Micha Lescot as Leloup Jean des Forêts as Alain Juppé

== Neuromodulator == GSNO, along with glutathione and oxidized glutathione (GSSG), have been found to bind to the glutamate recognition site of the NMDA and AMPA receptors (via their γ-glutamyl moieties), and may be endogenous neuromodulators. At millimolar concentrations, they may also modulate the redox state of the NMDA receptor complex.

The linker histone, or H1 protein, is also involved maintaining nucleosome structure. The H1 protein has the special role of ensuring that DNA stays tightly wound. Modifications to histone proteins and their DNA are classified as quaternary structure. Condensed chromatin, heterochromatin, prevents transcription of genes. In other words, transcription factors cannot access wound DNA- This is in contrast to euchromatin, which is decondensed, and therefore, readily accessible to the transcriptional machinery. DNA methylation to nucleotides influences chromatin quaternary structure. Highly methylated DNA nucleotides are more likely found within heterochromatin whereas unmethylated DNA nucleotides are common in euchromatin. Furthermore, post-translational modifications can be made to the core histone tail domains, which lead to changes in DNA quaternary structure and therefore gene expression. Enzymes, known as epigenetic writers and epigenetic erasers, catalyze either the addition or removal of several modifications to the histone tail domains. For instance, an enzyme writer can methylate Lysine-9 of the H3 core protein, which is found in the H3 histone tail domain. This can lead to gene repression as the chromatin gets remodeled and resembles heterochromatin. However, dozens of modifications can be made to histone tail domains. Therefore, it is the sum of all those modifications that determine whether chromatin will resemble heterochromatin or euchromatin.

Following concerns over the fate of 7-Eleven Speak Out Wireless customers, Quickie offered the option for SpeakOut customers to port into the Good2Go mobile provider. SpeakOut subsequently offered online sales as an option, and continues to offer Ottawa-based phone numbers to new and existing customers.

CGRP is released from both the trigeminal ganglion (TG) and the trigeminal nucleus caudalis (TNC) in response to trigeminal nerve activation. CGRP activates receptors on meningeal blood vessels, causing dilation and changes in blood flow. CGRP also activates specialized nerve endings in the dura mater (nociceptors) that transmit pain signals to the central nervous system. Increased neuronal activity in the trigeminal pain pathway reaches higher cortical pain regions via the brainstem, midbrain, and thalamus. Stimulation of the trigeminal nerve may result in the release of neuropeptides such as CGRP from nerve endings, release of inflammatory mediators from mast cells, vasodilation of cerebral and dural blood vessels, neurogenic inflammation, and the transmission of pain signals via nerves in the meninges. Cerebrospinal fluid may play a role in migraine by conveying signals from the brain to overlying pain-sensitive meningeal tissues, including the dura mater.

Sources: en.wikipedia.org

Frequently asked questions

What is the amino acid sequence of Semax?

The sequence is Met-Glu-His-Phe-Pro-Gly-Pro, a seven-residue peptide. The first four residues correspond to the ACTH(4-10) fragment, and Pro-Gly-Pro is added at the C-terminus. N-acetylated versions also appear in the literature and differ in mass.

How does Semax relate to ACTH?

Semax is a synthetic analog of the ACTH(4-10) fragment rather than a copy of the full hormone. Truncation plus the added tail removes the steroidogenic portion of ACTH. That distinction explains why it is studied for nervous-system effects instead of adrenal stimulation.

Is Semax an approved medicine?

It is registered as a prescription product in Russia and has been used there clinically, chiefly by the intranasal route. No approval exists in the United States or the European Union. Availability elsewhere typically falls under research-chemical distribution, with varying purity documentation.

What is Semax chemically?

It is a synthetic seven-amino-acid peptide built from the ACTH(4-7) sequence plus a Pro-Gly-Pro tail. It belongs to the family of short ACTH fragments studied for nervous-system effects. Its backbone contains only standard amino acids.

Network